{
    "pmcid": "9492400",
    "qa_pairs": {
        "What effect did the coexpression of candidate proteins with ACE2 have on the infectivity of a SARS-CoV-2 pseudovirus in HEK293T cells?": [
            "Enhanced the infectivity",
            "Reduced the infectivity",
            "Had no effect on the infectivity",
            "Completely inhibited the infectivity"
        ],
        "What is a key consideration for designing nanobodies to enhance cross-reactivity and efficacy against different viral strains?": [
            "Targeting conserved regions of the spike protein or its associated host proteins",
            "Focusing on variable regions of the spike protein",
            "Designing nanobodies that only bind to one specific viral strain",
            "Avoiding any interaction with host cell proteins"
        ],
        "What is the potential therapeutic application of nanobodies targeting the SARS-CoV-2 spike protein and its associated host cell proteins?": [
            "Inhibit viral entry and serve as effective antiviral agents",
            "Enhance viral replication within host cells",
            "Facilitate the spread of the virus between cells",
            "Increase the mutation rate of the virus"
        ],
        "What method was used to identify host cell membrane proteins in proximity to the SARS-CoV-2 spike protein?": [
            "Enzyme-Mediated Activation of Radical Source (EMARS)",
            "Mass spectrometry",
            "Western blotting",
            "CRISPR-Cas9 screening"
        ],
        "Which host cell membrane proteins were identified as being in close proximity to the SARS-CoV-2 spike protein?": [
            "DPP4, Cadherin 17, and CD133",
            "ACE2, TMPRSS2, and Furin",
            "Integrin, Laminin, and Fibronectin",
            "EGFR, HER2, and PD-L1"
        ]
    }
}